Pages with the fewest revisions
From IDWiki
Showing below up to 50 results in range #651 to #700.
- Eravacycline (1 revision)
- CR:DOI:c8fd75ef11c491c8a3a44052f8d4a5a6 (1 revision)
- CR:DOI:3917348f8490a2874a73be4769774c60 (1 revision)
- Conditioning regimens for HSCT (1 revision)
- CR:DOI:d0a6ae27f8da47002a176a60aae6a653 (1 revision)
- CR:DOI:45fdd9d93c8d6c80b99b6f38d0dccd38 (1 revision)
- Auricular chondritis (1 revision)
- Constrictive pericarditis (1 revision)
- CR:DOI:d79ef6403423785d7445a287d9f5298f (1 revision)
- CR:DOI:4dc6ace4215c8fc18ce986fa74da8519 (1 revision)
- IgG subclass deficiency (1 revision)
- CR:DOI:e4b88dce4876a095de40d59ac19b0407 (1 revision)
- CR:DOI:5489fb50cc5cc7d3646573606d6b0255 (1 revision)
- Model for end-stage liver disease (1 revision)
- Culiseta melanura (1 revision)
- CR:DOI:ed606f5d19db857530752a358b3e0da4 (1 revision)
- CR:DOI:5e57474ec7fa586d01386108222051f8 (1 revision)
- Bevacizumab (1 revision)
- Saddle nose deformity (1 revision)
- Perioperative medication management (1 revision)
- Moya moya syndrome (1 revision)
- Frailty (1 revision)
- CR:DOI:f38f70194f5cfa85addb1cbc85256919 (1 revision)
- CR:DOI:683a799d2c3a950ee88512dee71f0649 (1 revision)
- Abdominal compartment syndrome (1 revision)
- Delayed hemolytic transfusion reaction (1 revision)
- CR:DOI:6f8e66eb82d245ff8b10d0e5b39bd9f9 (1 revision)
- Valve replacement (1 revision)
- Serious illness conversation guide (1 revision)
- Nail pitting (1 revision)
- Candida auris (1 revision)
- CR:DOI:8362823c88e482f6d7cacb7d8f46b099 (1 revision)
- CHA2DS2-VASc (1 revision)
- Acute severe headache (1 revision)
- Vincent angina (1 revision)
- Post-transfusion purpura (1 revision)
- Gram-negative meningitis (1 revision)
- Dominant R-wave in V1 (1 revision)
- Cardiogenic shock (1 revision)
- CR:DOI:8e2bad092ff079112b6816a5cc9f7230 (1 revision)
- CR:DOI:040ca4f27ba6b86983650733d3b2c378 (1 revision)
- Cefixime (1 revision)
- CR:DOI:96250abe143582f71379fd5cc5a967ba (1 revision)
- CR:DOI:0bcc6847396585e08eeaa605a01ea527 (1 revision)
- Alemtuzumab (1 revision)
- Probe-to-bone test (1 revision)
- Non-alcoholic steatohepatitis (1 revision)
- Left atrial enlargement (1 revision)
- HLA-DR3 (1 revision)
- E. coli (1 revision)